Times New Roman

Media.Monks Launches AI-Powered Consumer Insight Solution Persona.Flow

Retrieved on: 
Monday, March 18, 2024

SAN JOSE, Calif., March 18, 2024 /PRNewswire/ -- S4Capital's operating brand Media.Monks, a digital-first, data-led advertising and marketing services company, has launched Persona.Flow, a professional managed service that gives brand marketers the ability to talk to their data. Persona.Flow marks a notable expansion to the existing Monks.Flow service. It addresses a unique need within enterprise AI workflows by converting owned customer data into dynamic consumer personas. This transformation allows marketers to interact in real-time, significantly augmenting their speed to market.

Key Points: 
  • It addresses a unique need within enterprise AI workflows by converting owned customer data into dynamic consumer personas.
  • Persona.Flow offers a user-friendly interface to help brands streamline strategy workflows, increase their precision, and democratize deep data insights.
  • Designed as a cost-effective alternative to traditional focus groups, Persona.Flow negates the need for the weeks of planning and deliberation that are commonly associated with building consumer intelligence.
  • This owned data fuels the AI workflows that brands increasingly rely on to deliver relevant content that audiences crave.

Compilation of quality review of documents (QRD) on stylistic matters in product information

Retrieved on: 
Sunday, March 10, 2024

29 February 2024

Key Points: 
    • 29 February 2024
      EMA/25090/2002 rev.23*
      Human Medicines Division

      Compilation of QRD decisions on stylistic matters in product information
      Issues
      Abbreviations

      Connected problems
      Subscript and superscript

      QRD Suggestions
      Acronyms must be written in their standard form; e.g.

    • Cmax, Cmax
      Abbreviations and

      Not always understood,

      Non-standard abbreviations and acronyms should be avoided, and the term should be written out in full.

    • The same applies when stating the pharmaceutical form in section 3 of the SmPC and section 4 of the labelling;
      i.e.
    • critical steps prior to administration of the product should also be included (section 5 of Annex IIIA).
    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 2/23

      Issues

      Connected problems

      QRD Suggestions

      emphasise in the labelling
      the special handling prior
      to administration of the
      product.

    • Consistency

      Inconsistencies in style are

      Once a particular style or house style has been selected, it must be used consistently throughout the text.

    • Tradename 150 mg solution for injection in pre-filled syringe
      Tradename 150 mg solution for injection in pre-filled pen

      information annexes?

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 3/23

      Issues
      Desiccant

      Connected problems

      QRD Suggestions

      For medicinal products

      The foil of blister packs containing a desiccant must be clearly labelled to show which blister pocket contains

      packaged with a desiccant

      the desiccant.

    • For bottles containing a desiccant, a similar statement should also be considered provided there

      mistake the desiccant for a

      is available space.

    • It can only be included in brackets in section 3 of the

      where can this be

      SmPC and section 4 of the labelling.

    • Direct speech should only
      be used in section 6 of the SmPC for instructions about shelf-life, storage, handling and disposal.
    • The term ?drug? though can be used in the product information annexes when it is part of a standard set of
      terms (e.g.
    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 5/23

      Issues
      Foreign terms

      Connected problems

      QRD Suggestions

      Foreign terms, particularly

      Foreign terms must be written in italics; e.g.

    • Patients can be referred to as ?he? or

      physician is often referred

      as ?she? when the medicinal product is exclusively for use by males or females.

    • if the product in question might be

      measurements are

      used by elderly patients), in brackets after the metric measures in the English text.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 6/23

      Issues

      Connected problems

      QRD Suggestions

      product name is composed
      of MAH+INN?

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 7/23

      Issues

      Connected problems

      QRD Suggestions
      MT: English
      BG: Bulgarian
      NL: Dutch
      CZ: Czech or English at applicant?s discretion.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 14/23

      Issues

      Connected problems

      QRD Suggestions
      considered, e.g.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 16/23

      Issues
      Symbols: Non-Unicode

      Connected problems

      QRD Suggestions

      The use of non-Unicode

      Only Unicode symbols must be used in submitted product information annexes.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 20/23

      Issues

      Connected problems

      Units: SI base units -

      International Standard

      litre

      base units have been
      introduced in the European
      Union with Council
      Directive 80/181/EEC of
      20.12.79 (O.J.

    • Compilation of QRD decisions on stylistic matters in product information
      EMA/25090/2002

      Page 23/23

Intelligent Scopes and Mayo Clinic Collaborate to Develop AI Diagnostic Solutions in Urology for Improved Patient Outcomes

Retrieved on: 
Thursday, December 21, 2023

LONDON and NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd. is pleased to announce it has entered into a know-how agreement with Mayo Clinic to develop artificial intelligence (AI) solutions for surgical and endoscopic imaging in the field of urology.

Key Points: 
  • LONDON and NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd. is pleased to announce it has entered into a know-how agreement with Mayo Clinic to develop artificial intelligence (AI) solutions for surgical and endoscopic imaging in the field of urology.
  • Combining the research capabilities and clinical expertise of Mayo Clinic, with the technology of Intelligent Scopes in image enhancement and expertise in development of precision AI diagnostic tools, this collaboration aims to deliver software tools that aid urologists in the detection, surgery, and post-treatment surveillance.
  • This digital healthcare collaboration intends to deliver reliable AI diagnostic solutions that can be used by urologists globally for accurate detection of bladder cancer and to minimize unnecessary interventions thereby improving patient outcomes.
  • Early and accurate detection has the potential to significantly improve the prognosis for patients and reduce costs to providers and payors.

Intelligent Scopes Corp, Subsidiary of Claritas HealthTech, to Lead Global Delivery of CystoSmart™, an AI-Assisted Diagnostic Software for Bladder Cancer Detection in Endoscopic Images

Retrieved on: 
Monday, November 13, 2023

Claritas, a leader in image enhancement and AI diagnostic solutions has developed pioneering technology for real-time precision detection of conditions in endoscopic and cystoscopic images.

Key Points: 
  • Claritas, a leader in image enhancement and AI diagnostic solutions has developed pioneering technology for real-time precision detection of conditions in endoscopic and cystoscopic images.
  • Bladder cancer is the 10th most common cancer in the world, and the 6th most common in men.
  • Diagnostics using cystoscopes for examination of the bladder is challenging, and time and resource intensive.
  • Our aim has been to develop an AI diagnostic tool that enhances the accuracy of detection of bladder cancers.

Claritas HealthTech Announces the Spin-Off of Intelligent Scopes Corp for Strategic Growth and Focused Delivery of Precision AI Diagnostic Solutions for Urology and Gastroenterology

Retrieved on: 
Friday, November 3, 2023

Claritas, headquartered in London, specializes in developing cutting-edge image processing, image enhancement and AI diagnostic tools across various modalities ranging from radiology and nuclear medicine to dermatology and ophthalmology.

Key Points: 
  • Claritas, headquartered in London, specializes in developing cutting-edge image processing, image enhancement and AI diagnostic tools across various modalities ranging from radiology and nuclear medicine to dermatology and ophthalmology.
  • Over the past two years, the company has developed pioneering technology for precision AI detection of conditions in endoscopic and cystoscopic images.
  • Chetan Baxi, CEO of Claritas commented, “With the establishment of Intelligent Scopes Corp, we will be able to strengthen our strategic focus and capitalize on growth opportunities.
  • Intelligent Scopes Corp aims to collaborate with the medical leaders in the field to deliver precise and targeted solutions for these requirements.”
    For media inquiries or further information, please contact:

Former P&G Exec Lisa Raimondo Joins Amazon Beauty Agency Market Defense as Chief Commercial Officer

Retrieved on: 
Monday, October 23, 2023

SEATTLE, Oct. 23, 2023 /PRNewswire/ -- Market Defense, the leading full-service global marketplace agency for beauty brands, has announced the appointment of Lisa Raimondo as its new Chief Commercial Officer.

Key Points: 
  • SEATTLE, Oct. 23, 2023 /PRNewswire/ -- Market Defense, the leading full-service global marketplace agency for beauty brands, has announced the appointment of Lisa Raimondo as its new Chief Commercial Officer.
  • Market Defense represents exceptional clients like Droplette, one of TIME's Best Inventions of 2022, Allure's Best Clean Skincare brand Alpyn Beauty, and the Oprah O award-winning Iles Formula.
  • "Stepping into the CCO role at Market Defense during such a transformative time is an exhilarating opportunity," shared Lisa Raimondo.
  • Lisa's proven track record in scaling businesses will be instrumental in driving revenue for our clients, partners, and Market Defense."

Sharecare confirms receipt of unsolicited proposal from Claritas Capital

Retrieved on: 
Thursday, October 12, 2023

Consistent with its fiduciary duties, the Company's Board of Directors will carefully review Claritas’ proposal with the Board’s advisors and pursue the course of action it determines to be in the best interests of the Company and all of its stockholders.

Key Points: 
  • Consistent with its fiduciary duties, the Company's Board of Directors will carefully review Claritas’ proposal with the Board’s advisors and pursue the course of action it determines to be in the best interests of the Company and all of its stockholders.
  • Sharecare stockholders do not need to take any action at this time.
  • There is no certainty that any transaction will be consummated, and Sharecare does not intend to comment further unless it determines that additional disclosure is appropriate.
  • The proposal was required to be disclosed by Claritas under Regulation 13D by the U.S. Securities and Exchange Commission.

New Claritas Report Projects that Remaining Lifetime Spending for the Average Hispanic Household Will Reach Nearly $2.5 Million

Retrieved on: 
Wednesday, October 4, 2023

The new, annual report offers marketers unique insight into the more than 67 million Hispanic individuals living the United States today.

Key Points: 
  • The new, annual report offers marketers unique insight into the more than 67 million Hispanic individuals living the United States today.
  • The Claritas report projects that the Hispanic population, which has added nearly 5 million members in the last four years alone, will add nearly 1.5 million new members each year through 2029.
  • Claritas projects that the average Hispanic household will spend almost $2.5 million over its remaining lifetime.
  • Members of the media can obtain a copy of The 2023 Hispanic Market Report by contacting Cort Irish at [email protected] .

Claritas HealthTech (Claritas) and Paragon Health IT (Paragon) Announce Strategic Partnership to Deliver AI Tools, Medical Image Processing , and Data Services to Global Medical Imaging Centers

Retrieved on: 
Tuesday, October 3, 2023

The synergies achieved will enable hospitals and imaging centres globally to easily adopt and utilize Claritas’ image processing technologies, together with Paragon’s streamlined data services, resulting in improved patient outcomes and efficient clinical workflows.

Key Points: 
  • The synergies achieved will enable hospitals and imaging centres globally to easily adopt and utilize Claritas’ image processing technologies, together with Paragon’s streamlined data services, resulting in improved patient outcomes and efficient clinical workflows.
  • Claritas, a company specializing in medical image enhancement and AI Diagnostic Tools, aims to deliver its FDA-Cleared software products for Radiology and Nuclear medicine through this platform to customers across North America.
  • Strings, created by Paragon, has data pipelines that are at the forefront of healthcare data management.
  • Chetan Baxi, CEO of Claritas, commented, “Our image enhancement and reconstruction software solutions provide significant benefits to our customers with improved image quality.

Claritas Acquires ArtsAI, the Fastest Growing AI Company in the Ad Technology Sector

Retrieved on: 
Tuesday, September 12, 2023

The acquisition, which will integrate ArtsAI’s patented, performance-enhancing technology into Claritas’ all-in-one marketing solution will accelerate client success by enhancing users’ ability to predictably drive highly personalized and profitable campaigns.

Key Points: 
  • The acquisition, which will integrate ArtsAI’s patented, performance-enhancing technology into Claritas’ all-in-one marketing solution will accelerate client success by enhancing users’ ability to predictably drive highly personalized and profitable campaigns.
  • Claritas’ acquisition of ArtsAI is the fourth in a series the company has made during its mission-based, five-year transformation to become the top closed-loop service provider in the industry.
  • “We’ve spent the last five years transforming the Claritas business to expand and enhance our value proposition to better meet our customers’ evolving needs”, said Claritas CEO Mike Nazzaro.
  • “Claritas’ acquisition of ArtsAI adds another layer of expertise & insights that we can leverage on behalf of our clients.